Deacetylravidomycin N-oxide

Deacetylravidomycin N-oxide is an antibiotic that can be produced by Streptomyces ravidus S50905. Deacetylravidomycin N-oxide is active against Gram-positive bacteria but inactive against Gram-negative bacteria. Deacetylravidomycin N-oxide has antitumor activity against P388 leukemia and methamphetamine A fibrosarcoma[1].

Product Specifications

CAS Number

[114494-30-3]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Infection

Smiles

C[C@@H]1[C@H](OC(C)=O)[C@H]([N+](C)([O-])C)[C@@H](O)[C@H](C2=C3C(C(OC)=CC4=C3OC(C5=CC(C=C)=CC(OC)=C54)=O)=C(O)C=C2)O1

Molecular Formula

C31H33NO10

Molecular Weight

579.59

References & Citations

[1]Narita T, et al. Deacetylravidomycin N-oxide, a new antibiotic. Taxonomy and fermentation of the producing organism and isolation, structure and biological properties of the antibiotic. J Antibiot (Tokyo) . 1989 Mar;42 (3) :347-56.